Study Provides Insight into Mitochondrial Dysfunction in Neurodegenerative Disorders

Johns Hopkins Medicine researchers have identified how proteins linked to Parkinson’s disease and amyotrophic lateral sclerosis (ALS) regulate mitochondrial health. Mitochondria, the energy-producing organelles in cells, rely on precise size control to function effectively. When stressed or damaged, mitochondria degrade, impairing cellular energy production and contributing to neurodegenerative conditions like Parkinson’s. The study, published in Nature, explores the roles of Parkin, PINK1, and OMA1 proteins in maintaining mitochondrial integrity.

Under normal conditions, cells protect mitochondria by repairing or dividing them. Parkin and PINK1 collaborate to enable mitochondrial fusion or degradation, while OMA1 inhibits fusion during stress. Genetic abnormalities in Parkin and PINK1 are tied to Parkinson’s onset, and OMA1 is associated with ALS. Using genetically engineered mice, the team tested how knocking out combinations of these genes affects mitochondrial function. Mice lacking two genes (e.g., Parkin and OMA1 or PINK1 and OMA1) exhibited stunted growth, movement issues, and oversized mitochondria in neurons. Single-gene knockouts, however, showed no abnormalities, suggesting mitochondrial fusion is safeguarded by a “double-locked” mechanism involving both mitochondrial membranes.

The team engineered 18 genetic variations in mice to confirm their findings. Despite mitochondrial enlargement in double-knockout mice, energy production (ATP levels) in brain cells remained unchanged. Further analysis revealed that oversized mitochondria leaked mitochondrial DNA into the cell’s cytosol, triggering interferons and sparking inflammation—a potential link to neurodegeneration.

“Working in tandem, Parkin-PINK1 and OMA1 act as guardians of mitochondria, ensuring that the organelles maintain their normal size and function,” explains Miho Iijima, Ph.D., co-lead researcher. Future studies will investigate how mitochondrial DNA leakage occurs in enlarged mitochondria and identify immune-responsive cell types involved in neuroinflammation. This work aims to clarify Parkinson’s disease mechanisms and uncover new therapeutic targets, advancing understanding of mitochondrial dysfunction in neurodegenerative disorders.